We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$430M
Cap. Flow
+$532M
Cap. Flow %
13.96%
Top 10 Hldgs %
44.45%
Holding
75
New
7
Increased
31
Reduced
8
Closed
7

Top Buys

Rank Stock Value
1
ALIT icon
Alight
ALIT
+$70.1M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$67.8M
3
MD icon
Pediatrix Medical
MD
+$59.9M
4
TDOC icon
Teladoc Health
TDOC
+$56.5M
5
CAR icon
Avis
CAR
+$53.3M

Top Sells

Rank Stock Value
1
IBIT icon
iShares Bitcoin Trust
IBIT
+$69.7M
2
ATMU icon
Atmus Filtration Technologies
ATMU
+$36.5M
3
PARR icon
Par Pacific Holdings
PARR
+$28.6M
4
PLYA
Playa Hotels & Resorts
PLYA
+$27.5M
5
ANIP icon
ANI Pharmaceuticals
ANIP
+$23M

Sector Composition

Rank Sector Weight
1 Healthcare 49.51%
2 Technology 9.09%
3 Industrials 7.78%
4 Financials 7.37%
5 Utilities 6.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SDGR icon
26
Schrodinger
SDGR
$1.4B
$60.5M 1.59%
3,130,000
+2,131,724
+214% +$49.1M
OPK icon
27
Opko Health
OPK
$1.04B
$55.5M 1.46%
44,422,304
+39,486,490
+800% +$51.2M
MREO
28
Mereo BioPharma
MREO
$48.8M
$55.1M 1.44%
15,307,347
+1,754,350
+13% +$5.68M
ADEA icon
29
Adeia
ADEA
$3.06B
$51.9M 1.36%
4,640,009
– –
ADPT icon
30
Adaptive Biotechnologies
ADPT
$4.04B
$50.7M 1.33%
14,000,000
+3,500,000
+33% +$11.1M
SSYS icon
31
Stratasys
SSYS
$782M
$50.1M 1.31%
5,968,703
+918,703
+18% +$8.73M
OFIX icon
32
Orthofix Medical
OFIX
$420M
$49M 1.28%
3,694,946
+29,946
+0.8% +$410K
PLAY icon
33
Dave & Buster's
PLAY
$349M
$48.8M 1.28%
1,225,000
+626,497
+105% +$32.5M
TDOC icon
34
Teladoc Health
TDOC
$1.24B
$45.3M 1.19%
+4,628,532
New +$56.5M
KNSA icon
35
Kiniksa Pharmaceuticals
KNSA
$6.07B
$45.2M 1.18%
2,419,103
+223,094
+10% +$4.18M
VYX icon
36
NCR Voyix
VYX
$1.11B
$42.4M 1.11%
3,437,030
-1,109,051
-24% -$14M
AIR icon
37
AAR Corp
AIR
$5.86B
$41.8M 1.1%
575,000
-150,000
-21% -$10.2M
ANIP icon
38
ANI Pharmaceuticals
ANIP
$1.71B
$38.4M 1.01%
603,800
-354,733
-37% -$23M
XPER icon
39
Xperi
XPER
$323M
$34M 0.89%
4,143,744
+100,000
+2% +$945K
ZYME icon
40
Zymeworks
ZYME
$1.73B
$33.3M 0.87%
3,917,331
+441,947
+13% +$3.93M
TAC icon
41
TransAlta
TAC
$3.95B
$33.2M 0.87%
4,687,158
– –
GDRX icon
42
GoodRx Holdings
GDRX
$1.3B
$29.1M 0.76%
3,736,802
+1,619,748
+77% +$12M
FIP icon
43
FTAI Infrastructure
FIP
$516M
$27.6M 0.72%
3,193,530
– –
RSKD icon
44
Riskified
RSKD
$705M
$26.7M 0.7%
4,173,636
– –
CNNE icon
45
Cannae Holdings
CNNE
$644M
$25.9M 0.68%
1,430,248
+216,031
+18% +$4.19M
GLNG icon
46
CALL
Golar LNG
GLNG
$5.17B
$21.9M 0.58%
+700,000
New +$18.5M
CHRS icon
47
Coherus Oncology
CHRS
$187M
$18M 0.47%
10,400,000
– –
SCPH
48
DELISTED
scPharmaceuticals
SCPH
$15.3M 0.4%
3,525,000
– –
CRS icon
49
Carpenter Technology
CRS
$26.7B
$15.3M 0.4%
139,806
+61,145
+78% +$5.87M
TRVI icon
50
Trevi Therapeutics
TRVI
$2.54B
$15M 0.39%
5,026,931
-537,192
-10% -$1.49M
1
2
3

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return

Rubric Capital Management (New York)'s Q2 2024 Portfolio in Review

As of Q2 2024, Rubric Capital Management (New York) held 75 positions worth $3.81B, up 13% from $3.38B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Rubric Capital Management (New York) deployed $532M of net new capital in Q2 2024, opening 7 new positions and adding to 31 existing holdings. Its largest new stake was Alight: 421,153 shares worth $62.2M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 48% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Playa Hotels & Resorts, an estimated $27.5M trimmed.

  • Rubric Capital Management (New York)'s largest Q2 2024 buy was Alight: 421,153 shares worth $62.2M.
  • Rubric Capital Management (New York) added most to Pediatrix Medical in Q2 2024, an estimated $59.9M increase.
  • Rubric Capital Management (New York)'s biggest Q2 2024 reduction was Playa Hotels & Resorts, cutting an estimated $27.5M.
  • Rubric Capital Management (New York) fully exited iShares Bitcoin Trust in Q2 2024, selling an estimated $69.7M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 44% of its $3.81B portfolio in Q2 2024.
  • Rubric Capital Management (New York) opened 7 new positions and closed 7 in Q2 2024.
  • Rubric Capital Management (New York)'s portfolio value rose 13% quarter-over-quarter to $3.81B.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2024, filed 13 Aug 2024.